Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
8.05
-0.82 (-9.24%)
At close: Jan 6, 2026, 4:00 PM EST
8.11
+0.06 (0.75%)
After-hours: Jan 6, 2026, 7:52 PM EST
Verrica Pharmaceuticals Market Cap
Verrica Pharmaceuticals has a market cap or net worth of $128.72 million as of January 6, 2026. Its market cap has increased by 103.04% in one year.
Market Cap
128.72M
Enterprise Value
143.36M
1-Year Change
103.04%
Ranking
Category
Stock Price
$8.05
Market Cap Chart
Since June 15, 2018, Verrica Pharmaceuticals's market cap has decreased from $436.56M to $128.72M, a decrease of -70.52%. That is a compound annual growth rate of -14.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 141.83M | 6.74% |
| Dec 31, 2025 | 132.88M | 109.60% |
| Dec 31, 2024 | 63.40M | -79.41% |
| Dec 29, 2023 | 307.91M | 172.47% |
| Dec 30, 2022 | 113.01M | -55.17% |
| Dec 31, 2021 | 252.07M | -15.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 933.04B |
| Johnson & Johnson | 489.06B |
| AbbVie | 389.18B |
| UnitedHealth Group | 310.20B |
| AstraZeneca | 280.48B |
| Novartis AG | 266.00B |
| Merck & Co. | 265.70B |
| Novo Nordisk | 241.55B |